| mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
-0.26 |
9e-06 |
| mRNA |
ABT-737 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
3e-05 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0001 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0002 |
| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
Rapamycin |
gCSI |
pan-cancer |
AAC |
-0.23 |
0.0002 |
| mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
| mRNA |
Docetaxel |
gCSI |
pan-cancer |
AAC |
-0.22 |
0.0004 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0004 |
| mRNA |
NVP-BSK805 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0005 |